InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,545.70
(
0.67%
)
US TECH 100
19,674.40
(
0.17%
)
Dow Jones
39,248.97
(
-0.15%
)
Brent Oil
87.25
(
-0.10%
)
Bitcoin
55,783.20
(
-2.10%
)
Post# of 58465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

The Holder

Send PM Follow Ignore
Followers 14
Posts 1160
Boards Moderated 0
Alias Born 12/19/2008

The Holder

Re: The Holder post# 11019

Wednesday, 03/04/2009 8:02:42 PM

Wednesday, March 04, 2009 8:02:42 PM

Post# of 58465
Genta CEO moves ahead despite financial crunch

BIO SmartBrief | 03/03/2009

Genta CEO Raymond Warrell Jr. is still determined to obtain FDA clearance for the company's lead product, cancer drug Genasense, despite the financial difficulties it faces. Warrell said he is working to raise funds to secure approval for Genasense and get Genta out of its cash crisis.

http://www.smartbrief.com/news/bio/storyDetails.jsp?issueid=29C58D72-590B-4D83-8067-DF50A1DC79C7©id=E18EE2FB-F7F3-40B1-92E8-048F7B9989A1&lmcid=
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up